Effects of aluminum and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: Relevance for the pathogenesis of Parkinson's disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1586, Issue 2, 2002, Pages 155-168

  Méndez Álvarez, Estefanía ^a   Soto Otero, Ramón ^a   Hermida Ameijeiras, Álvaro ^a   López Real, Ana María ^a   Labandeira García, José Luis ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

6 Hydroxydopamine; Aluminum; Antioxidant; Oxidative stress; Parkinson's disease; Zinc

Indexed keywords

ALUMINUM; ASCORBIC ACID; CYSTEINE; GLUTATHIONE; HYDROXIDE; OXIDOPAMINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TYROSINE 3 MONOOXYGENASE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOOXIDATION; BRAIN; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG POTENCY; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MALE; MITOCHONDRION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; RAT;

ADRENERGIC AGENTS; ALUMINUM; ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BRAIN; CATIONS; CYSTEINE; GLUTATHIONE; HYDROXYL RADICAL; MALE; MITOCHONDRIA; OXIDATIVE STRESS; OXIDOPAMINE; OXYGEN CONSUMPTION; POLAROGRAPHY; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; ZINC;

EID: 0037117309     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(01)00077-1     Document Type: Article

References (60)

1. Pathological considerations in the etiology of Parkinson's disease
2. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
3. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease
4. Oxidative stress and Parkinson's disease
5. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression
6. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: A combined retrograde tracing and immunocytochemical study in the rat
7. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine
8. Intermediates in the aerobic autoxidation of 6-hydroxydopamine: Relative importance under different reaction conditions
9. Nature of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine
10. Mechanism of inhibition of mitochondrial respiratory complex I by 6-hydroxydopamine and its prevention by desferrioxamine
11. Destruction of sympathetic nerve terminals by 6-hydroxydopamine: Protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyl-dithiocarbamate, methimazole, cysteamine, ethanol and n-butanol
12. Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-HODA) in rats: Behavioral and biochemical evidence
13. Free radical-generated neurotoxicity of 6-hydroxydopamine
14. Interactions between metals, ligands, and oxygen in the autoxidation of 6-hydroxydopamine: Mechanisms by which metal chelation enhances inhibition by superoxide dismutase
15. The role of transition metals in the pathogenesis of Parkinson's disease
16. Reactive oxygen species and the central nervous system
17. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: A LAMMA study
18. Diet, body size and micronutrient status in Parkinson's disease
19. Evidence of functional zinc deficiency in Parkinson's disease
20. Aluminum but not iron treatment induces pro-oxidant events in the rat brain
21. Oral aluminum administration and oxidative injury
22. Intraneuronal aluminum potentiates iron-induced oxidative stress in cultured rat hippocampal neurons
23. Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam
24. Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam
25. Status and future concerns of clinical and environmental aluminum toxicology
26. The antioxidant properties of zinc and metallothionein
27. Zinc protects against oxidative damage in cultured human retinal pigment epithelial cells
28. The antioxidant properties of zinc
29. 2+ exchanger
30. Zinc-induced cortical neuronal death with features of apoptosis and necrosis: Mediation by free radicals
31. Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release
32. The activation of lymphocyte plasma membrane (Na,K)-ATPase by EGTA is explained better by zinc than calcium chelation
33. Features of seizures and behavioral changes induced by intrahippocampal injection of zinc sulfate in the rabbit: A new experimental model of epilepsy
34. Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbid acid, and selected catechols
35. Effects of glutathione on Fenton reagent-dependent radical production and DNA oxidation
36. Autoxidation and neurotoxicity of 6-hydroxydopamine in the presence of some antioxidants: Potential implication in relation to the pathogenesis of Parkinson's disease
37. Effects of superoxide dismutase and catalase on catalysis of 6-hydroxydopamine and 6-aminodopamine autoxidation by iron and ascorbate
38. Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke
39. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples
40. Terephthalic acid: A dosimeter for the detection of hydroxyl radicals in vitro
41. In vitro inhibition of catalase activity by cigarette smoke: Relevance for oxidative stress
42. Electrochemical assay
43. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction
44. Distribution of ascorbic acid, metabolites, and analogues in man and animals
45. Lipid peroxidation facilitates aluminum accumulation in rat brain synaptosomes
46. Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: Increase susceptibility with aging
47. Glutathione-related enzymes in brain in Parkinson's disease
48. Ascorbate-stimulated lipid peroxidation in human brain is dependent on iron but not on hydroxyl radical
49. Aluminum has both oxidant and antioxidant effects in mouse brain membranes
50. Site-specific of lipid peroxidation by iron in charged micelles
51. Action of lead(II) and aluminium(III) ions on iron-stimulated lipid peroxidation in liposomes, erythrocytes and rat liver microsomal fractions
52. A mechanism for the stimulatory effect of aluminum on iron-induced lipid peroxidation
53. The chemistry of aluminum as related to biology and medicine
54. Effect of trivalent metal ions on phase separation and membrane lipid packing: Role in lipid peroxidation
55. Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum
56. Dopamine, 6-hydroxydopamine, iron, and dioxygen - Their mutual interactions and possible implication in the development of Parkinson's disease
57. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc
58. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia